2-(2-methoxyphenoxy)methyl-3-ethoxycarbonylacetyl-1,3-thiazolidine,
BBR 2173,
BBR-2173,
ethyl 2-((2-methoxyphenoxy)methyl)-beta-oxothiazolidine-3-propanoate,
moguisteine,
Moguisteine,
119637-67-1,
BBR-2173,
Moguisteine [INN],
Moguisteinum [INN-Latin],
Moguisteina [INN-Spanish],
C16H21NO5S,
Ethyl 2-((2-methoxyphenoxy)methyl)-beta-oxo-3-thiazolidinepropanoate (+-)-,
R,S(+-)-2-(2-Methoxyphenoxy)-methyl-3-ethoxycarbonylacetyl-1,3-thiazolidine,
3-Thiazolidinepropanoic acid, 2-((2-methoxyphenoxy)methyl)-beta-oxo-, ethyl ester, (+-)-,
Moguisteina,
Moguisteinum,
Ethyl (+-)-2-((o-methoxyphenoxy)methyl)-beta-oxo-3-thiazolidinepropionate,
ethyl 3-(2-((2-methoxyphenoxy)methyl)thiazolidin-3-yl)-3-oxopropanoate,
ethyl 3-[2-[(2-methoxyphenoxy)methyl]-1,3-thiazolidin-3-yl]-3-oxopropanoate,
Ethyl 3-{2-[(2-methoxyphenoxy)methyl]-1,3-thiazolidin-3-yl}-3-oxopropanoate,
BBR 2173,
ACMC-20d7cg,
AC1Q5JZ1,
Oprea1_020741,
MLS006010420,
SCHEMBL358534,
AC1L24A2,
CHEMBL146980,
CTK8E8094,
3-Thiazolidinepropanoicacid, 2-[(2-methoxyphenoxy)methyl]-b-oxo-, ethyl ester, (R)- (9CI),
HMS3264I22,
HMS3651H22,
Pharmakon1600-01502311,
BCP05219,
EBD54061,
HY-B0505,
KS-00001F7I,
2-(2-methoxyphenoxy)methyl-3-ethoxycarbonylacetyl-1,3-thiazolidine,
ethyl 2-((2-methoxyphenoxy)methyl)-beta-oxothiazolidine-3-propanoate,
MFCD00866839,
NSC759829,
s3104,
AKOS015843415,
AC-4727,
AN-6527,
BCP9000958,
CCG-213816,
CS-2706,
KS-5161,
NSC-759829,
RTC-070944,
VA11319,
121GE004,
AK343774,
SMR002529585,
LS-151527,
TC-070944,
FT-0084586,
FT-0656011,
SW219622-1,
BBR2173;BBR 2173;BBR-2173,
K-1384,
AB01563359_01,
AB01563359_02,
637M671,
A804330,
SR-01000944248,
I06-1738,
J-004167,
SR-01000944248-1,
BRD-A87673115-001-01-7,
(+/-)-2-(2-Methoxyphenoxy)-methyl-3-ethoxycarbonylacetyl-1,3-thiazolidine,
(R,S)-2-(2-Methoxyphenoxy)-methyl-3-ethoxycarbonyl-acetyl-1,3 thiazolidine,
ethyl 3-[2-[(2-methoxyphenoxy)methyl]thiazolidin-3-yl]-3-oxo-propanoate,
(+/-)-2-[(2-Methoxyphenoxy)methyl]-|A-oxo-3-thiazolidinepropanoic Acid Ethyl Ester,
3-[2-[(2-methoxyphenoxy)methyl]-3-thiazolidinyl]-3-oxopropanoic acid ethyl ester,
3-Thiazolidinepropanoic acid, 2-[(2-methoxyphenoxy)methyl]-beta-oxo-, ethyl ester,
3-Thiazolidinepropanoicacid, 2-[(2-methoxyphenoxy)methyl]-b-oxo-, ethyl ester,
ethyl 3-[2-[(2-methoxyphenoxy)methyl]-1,3-thiazolidin-3-yl]-3-oxidanylidene-propanoate,
(+/-)-2-(2-Methoxyphenoxy)-methyl-3-ethoxycarbonylacetyl-1,3-thiazolidine; (R,S)-2-(2-Methoxyphenoxy)-methyl-3-ethoxycarbonyl-acetyl-1,3 thiazolidine,
ethyl( inverted exclamation markA)-2-((o-methoxyphenoxy)methyl)-b-oxo-3-thiazolidinepropionate,
R(+)-Moguisteine,
S(-)-Moguisteine,
D0TR0Z,
Moguisteine < Rec INN >,
UNII-6Y556547YY,
BBR 2221,
BBR 2222,
CID65935,
C16-H21-N-O5-S,
6Y556547YY,
ACN-040065,
C087933,
126145-23-1,
Ethyl (R)-2-((2-methoxyphenoxy)methyl)-beta-oxo-3-thiazolidinepropanoate,
Ethyl (S)-2-((2-methoxyphenoxy)methyl)-beta-oxo-3-thiazolidinepropanoate,
Rac-3-[2-(Ethoxycarbonyl)acetyl]-2-(2-methoxyphenoxymethyl)thiazolidine,
Rac-2-[(2-Methoxyphenoxy)methyl]-beta-oxo-3-thiazolidinepropionic acid ethyl ester,
177313-65-4,